Back
ESC Premium Access

Age-dependent anti-thrombotic therapy for atrial fibrillation patients with intermediate risk (CHA2DS2-VASc Score of 1 or 2) of ischemic stroke

Session: Poster Session 5 - Atrial fibrillation and oral anticoagulation 4
Topic: Treatment
Speaker: Associate Professor S. Choi (Daegu, KR)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Sunyouong Choi

Daegu Health College, Daegu (Korea (Republic of))
0 follower

8 more presentations in this session

Oral anticoagulants in patients with atrial fibrillation having an intermediate risk of ischemic stroke but a high risk of bleeding

Speaker: Doctor T. Chao (Taipei, TW)

Access
Abstract
Like
Thumbnail

Older patients with atrial fibrillation and comorbidities are less likely to be treated with oral anticoagulation: insights from a nationwide study

Speaker: Doctor P. Rasmussen (Copenhagen, DK)

Access
Abstract
Slides
Like
Thumbnail

Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation in real-world clinical practice: the SPECTRUM post-approval safety study

Speaker: Professor J. Hartikainen (Kuopio, FI)

Access
Abstract
Slides
Like
Thumbnail

Mortality in patients with non-valvular atrial fibrillation in South America. Warfarin has significant higher global mortality rates versus dabigatran and rivaroxaban

Speaker: Doctor G. Vanerio (Montevideo, UY)

Access
Abstract
Like
Thumbnail

Effectiveness and safety of rivaroxaban versus warfarin in nonvalvular atrial fibrillation patients with coronary or peripheral artery disease

Speaker: Doctor C. Coleman (Storrs, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation and oral anticoagulation 4

Speakers: Associate Professor S. Choi, Doctor T. Chao, Doctor P. Rasmussen, Professor J. Hartikainen, Doctor G. Vanerio...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources